| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |